| Nov 14 |
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
|
| Nov 1 |
Galecto reports Q3 results
|
| Nov 1 |
Galecto Reports Third Quarter 2024 Financial Results
|
| Oct 18 |
Galecto price target raised to $10 from $9 at Oppenheimer
|
| Oct 15 |
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
|
| Oct 7 |
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines
|
| Aug 28 |
Galecto announces 1-for-25 reverse stock split
|
| Aug 28 |
Galecto Announces Reverse Stock Split
|
